Antiviral Drugs Market – Global Industry Analysis, Market Size Estimation, Growth Forecast By Type (Antiretroviral Drugs, Anti Herpes Virus Drugs, Anti Influenza Drugs, Interferons, Vaccines and Others), Mechanism of Action (Reverse Transcriptase (RT) Inhibitors, Uncoating Inhibitors, Protease Inhibitors, Fusion Inhibitors and Others) and Regions, 2017 – 2025

 
What Are the Main Reasons Behind the Growth of Antiviral Drugs Market?

  • Rise in diseases caused by new types of viruses such as Zika virus, Nipah virus, Ebola virus and Hendra virus
  • Growing numbers of patients who are required to take antiretroviral drugs to limit the effects of AIDS
  • Increasing market penetration of antiretroviral drugs

 

How Is The Market Segmented?
By Term Segments
By Type Antiretroviral Drugs, Anti-Herpes Virus Drugs, Anti-Influenza Drugs, Interferons, Vaccines and Others
By Mechanism of Action Reverse Transcriptase (RT) Inhibitors such as nucleoside RT inhibitors, non-nucleoside RT inhibitors, and nucleotide RT inhibitors; Uncoating Inhibitors, Protease Inhibitors, Fusion Inhibitors and Others
By Regions Asia Pacific, North America, Middle East & Africa (MEA), Europe and Latin America

 

Who Are The Major Players In This Market?
Headquarters Corporations
The U.S. Merck & Co., Inc., Bristol-Myers Squibb, Johnson & Johnson and others
England GlaxoSmithKline Plc and others
Switzerland F. Hoffmann-La Roche AG and others

 
Why Buy this Report?

  • This report provides in-depth analysis of market determinant factors.
  • It analyzes market dynamics for each segment (such as Type, Mechanism of Action, Regions).
  • The market report provides 8 years forecast by analyzing push and pull factors affecting the dynamics of the market.
  • This analysis report provides application level cross-sectional analysis for each product type.
  • It provides regional level pricing trend analysis.
  • The antiviral drugs market report acts as business decision support system by analyzing key trends in each market segment.
  • This research report provides insights regarding business strategies of leading market players.

Antiviral Drugs Market - Introduction

The global antiviral drugs market is expected to grow at a moderate pace during the forecast period 2017 to 2025. In the antiviral drugs market report, the market is segmented based on type, mechanism of action and regions. Antiviral drugs or antiviral pharmaceuticals are those medications which are utilized for prevention or treatment of diseases caused by viruses. These drugs are a type of antimicrobials and are mostly used for inhibiting the development or spread of a viral disease. Antiviral drugs are not similar to viricides since the latter is used for killing the viruses, while the former only inhibits the growth of viruses. Prescription antiviral drugs include ganciclovir, acyclovir, zidovudine, amantadine and oseltamivir among others. The growth in acquired immunodeficiency syndrome (AIDS) patients globally have been resulting in growing demand for antiretroviral drugs. Also, the four major classes of direct-acting antivirals are increasingly being used for the treatment of Hepatitis-C patients. The antiviral drugs market size and volume is primarily being driven by the increasing growth of virus-related diseases and patient pool globally.

Report Overview
Aspect Details
Base Year of Estimation 2016
Value Estimation Year 2017
Forecast Period 2017 - 2025
Market Segmentations By Type, Mechanism of Action, Regions
Regional Scope Asia Pacific, North America, Middle East & Africa (MEA), Europe and Latin America
Report Coverage Market Dynamics, Segmentation Overview and Competitive Landscape of the market

 

Market Dynamics

As per the studies conducted by World Health Organization (WHO) and Organization, around 36.7 million people had AIDS in 2015 while a significantly large number of people are unaware of whether they have AIDS or not. Such huge numbers of patients are required to take antiretroviral drugs for limiting the effects of AIDS. This, in turn, has been promoting the growth of the market for antiviral drugs.

The rise in diseases caused by new types of viruses has also been positively impacting the demand for antiviral drugs. Viruses such as Zika virus, Nipah virus, Ebola virus and Hendra virus are some of the new types of viruses which have been infecting a large population of people globally. Since these are newer types of viruses, the traditional antiviral drug therapies often are ineffective. This has led to high demand for newer types of antiviral treatments, thus growing the antiviral drugs market size.

While most common antiviral treatments have fewer side effects, antiretroviral drugs, however, has several side effects, coupled with the high price of branded treatment regimens. This, in turn, has been inhibiting the growth of the antiviral drugs market. However, WHO estimates that almost 70% of all AIDS patients are present in sub-Saharan Africa and also quite a less number of people has proper access to antiretroviral treatments. Market penetration of antiretroviral drugs in this region can be expected to offer high growth opportunities for the antiviral drugs market.

 

Segmentation Overview

The antiviral drugs market, based on type, can be segmented into antiretroviral drugs, anti-herpes virus drugs, anti-influenza drugs, interferons, vaccines and others. Antiretroviral drugs segment was the largest segment in 2016, owing to their higher price and huge patient pool. On the basis of the mechanism of action, the antiviral drugs market is segmented as reverse transcriptase (RT) inhibitors, uncoating inhibitors, protease inhibitors, fusion inhibitors and others. RT inhibitors have been further segmented into nucleoside RT inhibitors, non-nucleoside RT inhibitors, and nucleotide RT inhibitors. RT inhibitors were the largest segment in 2016 and include drugs such as zalcitabine, didanosine, delaviridine, nevirapine and tenofovir among others.

By geography, the market has been segmented into Asia-Pacific, North America, Middle East & Africa (MEA), Europe and Latin America. Owing to higher rates of research & development and growing number of initiatives for developing newer antiviral drugs, North America commanded the largest market share by revenue in 2016.

 

Competitive Landscape

The antiviral drugs industry study lists some of the major companies operating in this market. They are Merck & Co., Inc. (The U.S.), GlaxoSmithKline Plc (England), Bristol-Myers Squibb (The U.S.), Johnson & Johnson (The U.S.), and F. Hoffmann-La Roche AG (Switzerland) among others.

 

Related Upcoming Report Titles

Gout Therapeutics Market - Global Industry Insights Up to 2025

Prostate Cancer Therapeutics Market - Global Industry Insights Up to 2025

Transdermal Scopolamine Market Report - Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025

Pharmacologic Stress Agents Market Report - Global Industry Insights, Market Size Estimation, Up to 2025

Blood Pressure Monitoring Equipment Market Analysis Report - Global Industry Insights, Up to 2025

Dietary Supplements Market Research - Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025

Immunotherapy Drugs Market Analysis Report - Global Industry Insights, Market Size Estimation, Growth Forecast, 2017 - 2025

Contract Research Organization Market - Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025

Diet Management Products Market - Global Industry Insights, Market Size Estimation, Growth Forecast, Up to 2025

Get Free Samples for Market Research Reports. The privacy and security of your shared information are very important to us. Our website is secure and your personal details are safe.